Astrazeneca's Evusheld retains neutralizing activity against Omicron https://ift.tt/eA8V8J

The early data generated by pseudovirus testing of the full Omicron variant spike against the combination used in Evusheld provides preclinical evidence that it retains neutralizing activity against all tested variants of concern.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3m995HG
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.